Prescription decision
Online tirzepatide prescribing should clarify the care goal first
Tirzepatide is the active ingredient in branded products with different FDA-approved uses. Zepbound is labeled for chronic weight management and certain obstructive sleep apnea use in adults with obesity, while Mounjaro is labeled for type 2 diabetes. An online clinician should match the patient goal, label context, coverage path, medication list, and medical history before deciding whether tirzepatide, semaglutide, another option, or no prescription is appropriate.
- Ask whether the visit is reviewing branded Zepbound, branded Mounjaro, compounded tirzepatide, or another GLP-1 option.
- Coverage approval, a savings-card question, or cash-pay willingness does not replace medical eligibility review.
- A patient-specific prescription should come before pharmacy dispensing; a marketing quiz alone is not enough.